Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/17521
Title: Factors associated with nicotine replacement therapy use among hospitalised smokers.
Authors: Chui, Chang Yue;Thomas, Dennis;Taylor, Simone E;Bonevski, Billie;Abramson, Michael J;Paul, Eldho;Poole, Susan G;Weeks, Gregory R;Dooley, Michael J;George, Johnson
Affiliation: Centre for Medicine Use and Safety, Monash University, Melbourne, Australia
Department of Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands
Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia..
School of Medicine and Public Health, University of Newcastle, Newcastle, Australia
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Clinical Haematology Department, The Alfred, Melbourne, Australia
Pharmacy Department, Alfred Health, Melbourne, Australia
Pharmacy Department, Barwon Health, Geelong, Australia
Issue Date: 7-Feb-2018
EDate: 2018
Citation: Drug and alcohol review 2018; online first: 7 February
Abstract: Nicotine replacement therapy (NRT) is recommended as a smoking cessation aid for hospitalised smokers. We examined factors associated with NRT use during hospitalisation and after discharge, and NRT uptake when systematically offered free of cost. A nested analysis was conducted using data from a clinical trial that evaluated the effectiveness of a pharmacist-led smoking cessation intervention in 600 hospitalised smokers. NRT was used at least once by 285 (48%) participants during hospitalisation and by 287 (48%) participants during the 12 months post-discharge. Heavy smokers and those who expressed interest in using NRT for their next quit attempt at baseline interview were more likely to use NRT during hospitalisation [odds ratio (OR) 1.94, 95% confidence interval (CI) 1.38, 2.74; OR 2.09, 95% CI 1.48, 2.95] and after discharge (OR 1.70, 95% CI 1.20, 2.41; OR 1.97, 95% CI 1.39, 2.79). Those using six or more medications were more likely to use NRT during hospitalisation (OR 1.65, 95% CI 1.05, 2.61). Post-discharge NRT users were more likely to have been initially admitted for a respiratory or cardiac problem (OR 1.51, 95% CI 1.05, 2.18). When NRT was offered free of cost to a subset of patients (n = 300), 157 (52%) used NRT during hospitalisation. Nicotine dependence and interest in using NRT predicted its use (OR 2.26, 95% CI 1.38, 3.70; OR 2.58, 95% CI 1.58, 4.20). Targeting heavy smokers, those with cardio-respiratory conditions and those interested in using NRT regardless of regimen complexity could improve NRT uptake.
URI: http://ahro.austin.org.au/austinjspui/handle/1/17521
DOI: 10.1111/dar.12661
ORCID: 0000-0003-1978-1591
0000-0002-0592-518X
PubMed URL: 29411446
Type: Journal Article
Subjects: hospitalisation
nicotine replacement therapy
smoking
smoking cessation
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.